Dr. Gaber is a pharmacoepidemiologist whose applied research focuses on the use, effectiveness, and safety of cancer-directed therapies in older adults diagnosed with genitourinary and gastrointestinal cancers. He seeks to produce robust real-world evidence on the comparative effectiveness of therapies by leveraging observational data from cancer registries, claims databases, and electronic health records.
Charles Gaber, PhD, MPH
Research Assistant Professor
Department of Pharmacy Systems - Outcomes and Policy
College of Pharmacy
Research Program
Cancer Prevention And Control (CPC)
Email: [email protected]